• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于监督学习模型识别 SARS-CoV-2 的早期症状。

Supervised Machine Learning Models to Identify Early-Stage Symptoms of SARS-CoV-2.

机构信息

Department of Computer Engineering and Informatics, University of Patras, 26504 Patras, Greece.

出版信息

Sensors (Basel). 2022 Dec 21;23(1):40. doi: 10.3390/s23010040.

DOI:10.3390/s23010040
PMID:36616638
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9824026/
Abstract

The coronavirus disease (COVID-19) pandemic was caused by the SARS-CoV-2 virus and began in December 2019. The virus was first reported in the Wuhan region of China. It is a new strain of coronavirus that until then had not been isolated in humans. In severe cases, pneumonia, acute respiratory distress syndrome, multiple organ failure or even death may occur. Now, the existence of vaccines, antiviral drugs and the appropriate treatment are allies in the confrontation of the disease. In the present research work, we utilized supervised Machine Learning (ML) models to determine early-stage symptoms of SARS-CoV-2 occurrence. For this purpose, we experimented with several ML models, and the results showed that the ensemble model, namely Stacking, outperformed the others, achieving an Accuracy, Precision, Recall and F-Measure equal to 90.9% and an Area Under Curve (AUC) of 96.4%.

摘要

新型冠状病毒肺炎(COVID-19)疫情由 SARS-CoV-2 病毒引起,始于 2019 年 12 月。该病毒最初在中国武汉地区被报告。这是一种新型冠状病毒,此前从未在人类中分离出来。在严重的情况下,可能会发生肺炎、急性呼吸窘迫综合征、多器官衰竭甚至死亡。现在,疫苗、抗病毒药物和适当的治疗方法的存在是对抗这种疾病的盟友。在目前的研究工作中,我们利用有监督的机器学习(ML)模型来确定 SARS-CoV-2 发生的早期症状。为此,我们尝试了几种 ML 模型,结果表明,集成模型,即堆叠,表现优于其他模型,达到了 90.9%的准确率、90.9%的精度、90.9%的召回率和 90.9%的 F 值,以及 96.4%的曲线下面积(AUC)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea7b/9824026/099f6b732a2f/sensors-23-00040-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea7b/9824026/175ce76d23c2/sensors-23-00040-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea7b/9824026/099f6b732a2f/sensors-23-00040-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea7b/9824026/175ce76d23c2/sensors-23-00040-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea7b/9824026/099f6b732a2f/sensors-23-00040-g002.jpg

相似文献

1
Supervised Machine Learning Models to Identify Early-Stage Symptoms of SARS-CoV-2.基于监督学习模型识别 SARS-CoV-2 的早期症状。
Sensors (Basel). 2022 Dec 21;23(1):40. doi: 10.3390/s23010040.
2
A new hybrid ensemble machine-learning model for severity risk assessment and post-COVID prediction system.一种新的混合集成机器学习模型,用于严重程度风险评估和 COVID 后预测系统。
Math Biosci Eng. 2022 Apr 13;19(6):6102-6123. doi: 10.3934/mbe.2022285.
3
Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.中国武汉严重肺炎患者的临床特征。
Respiration. 2020;99(8):649-657. doi: 10.1159/000507940. Epub 2020 Aug 25.
4
PhosBERT: A self-supervised learning model for identifying phosphorylation sites in SARS-CoV-2-infected human cells.PhosBERT:一种用于识别 SARS-CoV-2 感染人类细胞中磷酸化位点的自监督学习模型。
Methods. 2024 Oct;230:140-146. doi: 10.1016/j.ymeth.2024.08.004. Epub 2024 Aug 22.
5
Early-stage predictors of deterioration among 3145 nonsevere SARS-CoV-2-infected people community-isolated in Wuhan, China: A combination of machine learning algorithms and competing risk survival analyses.中国武汉对 3145 例社区隔离的非重症 SARS-CoV-2 感染者进行早期恶化预测:机器学习算法和竞争风险生存分析的联合应用。
J Evid Based Med. 2023 Jun;16(2):166-177. doi: 10.1111/jebm.12529. Epub 2023 Apr 26.
6
Machine learning-based analysis of alveolar and vascular injury in SARS-CoV-2 acute respiratory failure.基于机器学习的 SARS-CoV-2 急性呼吸衰竭肺泡和血管损伤分析。
J Pathol. 2021 Jun;254(2):173-184. doi: 10.1002/path.5653. Epub 2021 Mar 30.
7
Machine learning techniques for sequence-based prediction of viral-host interactions between SARS-CoV-2 and human proteins.基于序列的 SARS-CoV-2 与人类蛋白质之间病毒-宿主相互作用的预测的机器学习技术。
Biomed J. 2020 Oct;43(5):438-450. doi: 10.1016/j.bj.2020.08.003. Epub 2020 Sep 3.
8
Clinical Features of Emergency Department Patients from Early COVID-19 Pandemic that Predict SARS-CoV-2 Infection: Machine-learning Approach.早期新冠疫情期间急诊科患者的临床特征预测 SARS-CoV-2 感染:机器学习方法。
West J Emerg Med. 2021 Mar 4;22(2):244-251. doi: 10.5811/westjem.2020.12.49370.
9
The Pandemic of Coronavirus Disease 2019 (COVID-19).2019 年冠状病毒病(COVID-19)大流行。
Curr Mol Med. 2022;22(9):761-765. doi: 10.2174/1566524021666211117145216.
10
Ensemble Machine Learning Model to Predict SARS-CoV-2 T-Cell Epitopes as Potential Vaccine Targets.用于预测作为潜在疫苗靶点的SARS-CoV-2 T细胞表位的集成机器学习模型
Diagnostics (Basel). 2021 Oct 26;11(11):1990. doi: 10.3390/diagnostics11111990.

引用本文的文献

1
Predicting SARS-CoV-2-specific CD4 and CD8 T-cell responses elicited by inactivated vaccines in healthy adults using machine learning models.使用机器学习模型预测灭活疫苗在健康成年人中引发的SARS-CoV-2特异性CD4和CD8 T细胞反应。
Clin Exp Med. 2025 Jul 8;25(1):236. doi: 10.1007/s10238-025-01772-2.
2
A machine learning model predicts stroke associated with blood cadmium level.机器学习模型预测与血镉水平相关的中风。
Sci Rep. 2024 Jun 26;14(1):14739. doi: 10.1038/s41598-024-65633-w.
3
Analysis and Prediction of COVID-19 Multivariate Data Using Deep Ensemble Learning Methods.

本文引用的文献

1
Comparison of machine learning methods with logistic regression analysis in creating predictive models for risk of critical in-hospital events in COVID-19 patients on hospital admission.比较机器学习方法与逻辑回归分析在建立 COVID-19 患者入院时危重症院内事件风险预测模型中的应用。
BMC Med Inform Decis Mak. 2022 Nov 28;22(1):309. doi: 10.1186/s12911-022-02057-4.
2
Machine Learning Methods for Hypercholesterolemia Long-Term Risk Prediction.机器学习方法在高胆固醇血症长期风险预测中的应用。
Sensors (Basel). 2022 Jul 18;22(14):5365. doi: 10.3390/s22145365.
3
Data-Driven Machine-Learning Methods for Diabetes Risk Prediction.
使用深度集成学习方法分析和预测 COVID-19 多变量数据。
Int J Environ Res Public Health. 2023 May 24;20(11):5943. doi: 10.3390/ijerph20115943.
4
SARS-CoV-2 Surveillance Through China Influenza Surveillance Information System - China, December 1, 2022 to February 12, 2023.通过中国流感监测信息系统开展的新型冠状病毒2019变异株监测 - 中国,2022年12月1日至2023年2月12日
China CDC Wkly. 2023 Feb 17;5(7):152-158. doi: 10.46234/ccdcw2023.027.
5
Long-Term Coronary Artery Disease Risk Prediction with Machine Learning Models.基于机器学习模型的长期冠状动脉疾病风险预测。
Sensors (Basel). 2023 Jan 20;23(3):1193. doi: 10.3390/s23031193.
6
Efficient Data-Driven Machine Learning Models for Cardiovascular Diseases Risk Prediction.高效数据驱动的机器学习模型在心血管疾病风险预测中的应用。
Sensors (Basel). 2023 Jan 19;23(3):1161. doi: 10.3390/s23031161.
基于数据驱动的机器学习方法在糖尿病风险预测中的应用。
Sensors (Basel). 2022 Jul 15;22(14):5304. doi: 10.3390/s22145304.
4
Stroke Risk Prediction with Machine Learning Techniques.基于机器学习技术的中风风险预测。
Sensors (Basel). 2022 Jun 21;22(13):4670. doi: 10.3390/s22134670.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show.新冠病毒变异株奥密克戎:早期数据显示,流鼻涕、头痛和疲劳是其最常见的症状。
BMJ. 2021 Dec 16;375:n3103. doi: 10.1136/bmj.n3103.
7
COVID-19 pneumonia: pathophysiology and management.COVID-19 肺炎:病理生理学与管理。
Eur Respir Rev. 2021 Oct 20;30(162). doi: 10.1183/16000617.0138-2021. Print 2021 Dec 31.
8
Machine learning application for the prediction of SARS-CoV-2 infection using blood tests and chest radiograph.利用血液检测和胸部 X 光预测 SARS-CoV-2 感染的机器学习应用。
Sci Rep. 2021 Jul 9;11(1):14250. doi: 10.1038/s41598-021-93719-2.
9
Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.评估 COVID-19 患者持续性症状的频率和种类:系统评价。
JAMA Netw Open. 2021 May 3;4(5):e2111417. doi: 10.1001/jamanetworkopen.2021.11417.
10
Contribution of machine learning approaches in response to SARS-CoV-2 infection.机器学习方法在应对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染中的作用。
Inform Med Unlocked. 2021;23:100526. doi: 10.1016/j.imu.2021.100526. Epub 2021 Jan 24.